Schedule 13G ownership disclosure
C4 Therapeutics Inc
Security class unavailable · CUSIP: 12529R107
Event date: 2024-01-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,312,059
- Percent of class
- 4.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-24-000047
- Form type
- SC 13G
- Filer
- C4 Therapeutics, Inc.
- CIK
- CIK 1662579
- Filed
- Jan 04, 2024
- Reporting period
- Jan 03, 2024
- Description
- Schedule 13G beneficial ownership